WeVote
Log In

Bill

Bill

HB 1365

Taxes - As introduced, changes from March 31 to March 1, the date by which the department of transportation must transmit to the governor and speakers of both houses its annual report listing the litter prevention programs receiving funds from the 0.4 percent increase in the gross receipts tax on bottled soft drinks, the amount of funds received by the programs, and the purpose for which the funds were spent. - Amends TCA Title 67.

114th Regular Session (2025-2026) Introduced by Jesse Chism

PA HB1365 would establish statewide public health notification programs and a Medication-Induced Movement Disorders Screening Education Program for providers and patients.

P2C, caption bill, held on desk - pending amdt.
#taxes
0
WeVote Research Nonpartisan
Bill Summary · HB 1365

Summary — HB 1365 (as identified by title and metadata)

Note: The material you provided includes multiple different bills labeled “HB 1365” from several states (IL, MD, ND, AR, IN) and other documents that are not the Pennsylvania measure referenced in your header. I did not find the actual Pennsylvania bill text in the documents supplied. The summary below is therefore based on the bill title and the available metadata you gave: “An Act amending Title 35 (Health and Safety) of the Pennsylvania Consolidated Statutes, providing for public health notification programs; and establishing the Medication‑Induced Movement Disorders Screening Education Program.” If you can provide the bill text or a link to it, I will produce a detailed provision‑level summary.

Main purpose and intent

  • Establish statewide programs within Pennsylvania law to (1) standardize or expand public health notification programs and (2) create a Medication‑Induced Movement Disorders Screening Education Program.
  • Likely goals: improve timely public health notifications to providers/patients/communities and increase screening, recognition, education, and possibly referral pathways for medication‑induced movement disorders (e.g., tardive dyskinesia, drug‑induced parkinsonism).

Key topics the bill title indicates it would address

  • Public health notification programs
    • Authorization or expansion of programs to notify affected individuals or providers about public health risks, exposures, outbreaks, recalls, or surveillance findings.
    • Could include required content, delivery methods (email/text/phone/mail), responsible agencies (e.g., PA Department of Health), data sharing rules, and privacy safeguards.
    • May set timelines and procedures for issuing notifications and for coordinating with local health departments and clinical providers.
  • Medication‑Induced Movement Disorders Screening Education Program
    • Establish an educational and screening initiative focused on movement disorders caused by medications (likely antipsychotics, certain antiemetics, etc.).
    • Could require or encourage provider training, patient education materials, screening tools or protocols, and referral/monitoring pathways.
    • May name the administering body (e.g., Department of Health) and outline duties, reporting, and evaluation metrics.

Who would be affected

  • Patients taking medications known to cause movement disorders (particularly long‑term antipsychotic users).
  • Prescribers and pharmacists (education, screening responsibilities, or notification roles).
  • Health care facilities and clinics (implementation of screening protocols).
  • Department(s) of Health and local public health agencies (administration of notification programs and the education program).
  • Potentially insurers or Medicaid if screening or training involves covered services.

Procedural/status information (from metadata)

  • Introduced: November 15, 2024
  • Status: Referred to Health (committee)
  • Next steps typically: committee hearings, possible amendments, committee vote, floor consideration, passage/defeat, concurrence (if amended), and enactment.

Important missing details (need bill text to confirm)

To produce a comprehensive, provision‑level summary I need the actual bill language. Key items I cannot confirm from the title alone:
- Definitions used (e.g., which movement disorders, which medications).
- Whether screening/education is mandatory or voluntary.
- Specific duties, timelines, funding (appropriations or grant authority), and enforcement mechanisms.
- Reporting requirements, performance metrics, or effective date.
- Any privacy/data‑sharing or liability protections.

Suggested next steps

  • Please provide the full Pennsylvania HB 1365 text or a link to the bill file (PA General Assembly website or bill PDF).
  • If you want, I can prepare:
    • A short summary for public audiences (1–2 paragraphs).
    • A detailed section‑by‑section synopsis once the text is available.
    • A concise bill comparison to current law (Title 35 PA Consolidated Statutes) highlighting exact changes.

If you supply the bill text, I’ll draft the full 200–500 word legislative summary with specific provisions, affected parties, and any fiscal/timeline implications.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.